Closed · CDC-RFA-GH22-2272 · CFDA 93.185 · Discretionary
Informing global polio eradication efforts through innovative modeling approaches
Federal grant opportunity posted by Centers for Disease Control - CGH, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- May 6, 2022
- Close date
- 2
- Expected awards
The verdict
Informing global polio eradication efforts through innovative modeling approaches is a closed discretionary listing from Centers for Disease Control - CGH that offered Varies by applicant across 2 expected awards. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 2
- expected awards
- 93.185
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Informing global polio eradication efforts through innovative modeling approaches - is cataloged under number CDC-RFA-GH22-2272 and tied to CFDA assistance listing 93.185, posted by Centers for Disease Control - CGH. Grants.gov currently shows the opportunity as closed, first posted on March 7, 2022. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is Varies by applicant. The agency has projected $1.8 million in total estimated funding for this announcement. It expects to issue 2 awards. If the agency funds the expected 2 awards from the $1.8 million estimated pool, the average award works out to roughly $875,000. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on May 6, 2022. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
May 6, 2022
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Posted
March 7, 2022
Est. Total Funding
$1,750,000
Expected Awards
2
Instrument
Cooperative Agreement
Description
The Global Polio Eradication Initiative (GPEI) began in 1988 with the objective of wild poliovirus (WPV) eradication and ultimate eradication of all polioviruses, including vaccine-derived polioviruses (VDPV). The Centers for Disease Control and Prevention (CDC) is one of the founding partners of the GPEI, providing technical and financial support (https://polioeradication.org/). Polio eradication remains an agency-wide priority; CDC's Emergency Operations Center (EOC) has been activated since December 2011 to support global polio response activities. The GPEI has made tremendous progress toward global WPV eradication, from 125 countries in 1988 to two countries in 2021. WPV types 2 and 3 have been eradicated and only WPV type 1 (WPV1) remains. Of WHO’s six Regions, only the Eastern Mediterranean Region remains affected. The GPEI faces two major challenges: 1) continued transmission of WPV1 in Pakistan and Afghanistan and 2) increasing number of circulating vaccine-derived poliovirus (cVDPVs) which result from prolonged transmission in under-immunized communities of the live weakened virus from the oral poliovirus vaccine (OPV). GPEI’s newest strategy, Polio Eradication Strategy 2022-2026: Delivering on a Promise, outlines how the partnership intends to address these challenges. Concurrently, GPEI must begin planning now for the future of a polio-free world. Current planning is that within 12 months of certification of WPV eradication, all OPVs will be removed from essential immunization programs (i.e., OPV cessation). The risk of emergence of VDPVs will be highest in the first two years after OPV cessation as intestinal mucosal immunity needed to stop virus transmission wanes. The risk of accidental introduction in communities and the environment by a containment breach from a poliovirus essential facility (PEF), such as a poliovirus vaccine manufacturer, will persist as long as live polioviruses are maintained at facilities. Numerous key questions remain about interrupting cVDPV transmission in the near-term, and the long-term needs of poliovirus surveillance. For cVDPV interruption, the focus is on which factor or combination of factors would optimize field-level response strategies to quickly interrupt transmission and associated costs. Questions on long-term surveillance needs include the optimal mix of poliovirus surveillance systems and activities that will be sustainable yet sensitive to detect emergence of VDPV and associated costs. In countries that have PEFs, questions are focused on the types of surveillance activities that should be implemented to ensure surveillance sensitivity around the PEF. Statistical and mathematical modeling would be an informative approach to address these questions. CDC has almost 20 years of experience working with modelers to address complex polio eradication issues to inform GPEI policymaking through cooperative agreements (NU2RGH001913, NU2RGH001915). Further expansion of the portfolio of models available to CDC is needed to include models that inform the most efficient and cost-effective field-level operations for outbreak response, and poliovirus surveillance needs in the post-certification era. In parallel, there is a recognized need for expanding the role of modeling to inform public health strategies and goals. CDC supports the growth of a diverse public health workforce and aims to provide collaborative opportunities to students to gain hands-on training and translation of their work to action. The benefit of such a collaboration will also increase modeling literacy among CDC staff.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25, 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Mary Mulholland, Extramural Team Lead, Global Immunization Division ZQL0@cdc.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |